While many people see a wonderful reduction in shedding and an increase in hair thickness, these benefits last when you stick with your maintenance plan
Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes
The blue color is from the copper
GHRP-2 and GHRP-6 both raise cortisol by 30 to 60% above baseline in human studies, which partially offsets the anabolic signal from the concurrent GH rise 1
This means the peptide lacks the safety and efficacy validation that comes with full regulatory approval
(EASY Pharmacology) How do GLP-1 Agonists work